SAN DIEGO, Oct. 25 – Caliper Technologies on Thursday posted third-quarter revenues of $6.6 million compared to $5.5 million for the same quarter a year ago, the company announced.

Caliper, based in Mountain View, Calif., recorded a net loss of $8.4 million, or 35 cents per diluted share, for the third quarter of 2001 compared to a net gain of $6.1 million, or 25 cents per diluted share, for the year-ago quarter. Operating expenses increased to $17.2 million for the third quarter of this year from $13.3 million in the same period in 2000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.